Cargando…

Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity

Cytokines are implied in polymyositis/dermatomyositis (PM/DM) pathogenesis. Our aim was to evaluate the serum levels of interleukin-15 (IL-15), soluble receptors for IL-2 (sIL-2R) and TNF-alpha type 1 receptor (sTNF-R1) in PM/DM patients and their relation to disease activity and clinical symptoms....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mielnik, Pawel, Chwalinska-Sadowska, Hanna, Wiesik-Szewczyk, Ewa, Maslinski, Wlodzimierz, Olesinska, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291833/ https://www.ncbi.nlm.nih.gov/pubmed/21132303 http://dx.doi.org/10.1007/s00296-010-1692-y

Ejemplares similares

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
por: Liu, Tao, et al.
Publicado: (2017)

Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development
por: Kurowska, Weronika, et al.
Publicado: (2020)

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all
por: Więsik-Szewczyk, Ewa
Publicado: (2021)

Nutrition and Polymyositis and Dermatomyositis
por: Loell, Ingela, et al.
Publicado: (2008)

Viral Etiology of Polymyositis/Dermatomyositis
por: DENMAN, A.M.
Publicado: (1988)

Subcutaneous Edema in Polymyositis and Dermatomyositis
por: Yoshimi, Ryusuke, et al.
Publicado: (2023)

Polymyositis and dermatomyositis: Disease spectrum and classification
por: Raychaudhuri, Siba P, et al.
Publicado: (2012)

Polymyositis and dermatomyositis – challenges in diagnosis and management
por: Yang, Shu-Han, et al.
Publicado: (2019)

Dermatomyositis and polymyositis in total hip arthroplasty
por: Rosas, Samuel, et al.
Publicado: (2021)

Treatment of rheumatic diseases and hepatitis B virus coinfection
por: Felis-Giemza, Anna, et al.
Publicado: (2014)

Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
por: Waldmann, Thomas A
Publicado: (2004)

Polymyositis and dermatomyositis as a risk of developing cancer
por: Jakubaszek, Michał, et al.
Publicado: (2015)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches
por: Trybuch, Agnieszka, et al.
Publicado: (2023)

New Onset of Dermatomyositis/Polymyositis during Anti-TNF-α Therapies: A Systematic Literature Review
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2014)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
por: Hirai, Takuya, et al.
Publicado: (2018)

Potential role of autophagy in T-cell survival in polymyositis and dermatomyositis
por: Shu, Xiaoming, et al.
Publicado: (2017)

B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
por: Wiesik-Szewczyk, E, et al.
Publicado: (2012)

Monogenic autoinflammatory diseases in adults – a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment
por: Milchert, Marcin, et al.
Publicado: (2019)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
por: Silva, Marilda Guimarães, et al.
Publicado: (2018)

STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018)

Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis
por: Chen, Si, et al.
Publicado: (2022)

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
por: Oddis, Chester V., et al.
Publicado: (2022)

Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation
por: Schmid, Anja Sophie, et al.
Publicado: (2019)

Interleukin 6 blockage-induced neutropenia in a patient with rheumatoid arthritis and resolved hepatitis B
por: Chmielińska, Magdalena, et al.
Publicado: (2016)

Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.
por: De Giovanni, C., et al.
Publicado: (1998)

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
por: Chen, Yi-Ju, et al.
Publicado: (2010)

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
por: Kim, Geun-Tae, et al.
Publicado: (2009)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis—A Cross-Sectional Study
por: Nissan, Ella, et al.
Publicado: (2021)

Supervised Physical Therapy and Polymyositis/Dermatomyositis—A Systematic Review of the Literature
por: Corrado, Bruno, et al.
Publicado: (2020)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
por: liu, mei, et al.
Publicado: (2023)

Interleukins and Interleukin Receptors Evolutionary History and Origin in Relation to CD4+ T Cell Evolution
por: Kubick, Norwin, et al.
Publicado: (2021)

Interleukin-7 and Interleukin-15 for Cancer
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Production of Bioactive Soluble Interleukin-15 in Complex with Interleukin-15 Receptor Alpha from a Conditionally-Replicating Oncolytic HSV-1
por: Gaston, David C., et al.
Publicado: (2013)

HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients
por: Grundtman, C, et al.
Publicado: (2003)

Coadministration of Cyclosporin A with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
por: da Cunha, Gilmara Franco, et al.
Publicado: (2013)

Thrombotic Microangiopathy with Polymyositis/Dermatomyositis: Three Case Reports and a Literature Review
por: Yamada, Saeko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_47c6ts33sffk972ongila57b5b